BackOutlook Therapeutics Overview

Outlook Therapeutics Other Assets

Track Outlook Therapeutics's other assets ($15M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Assets
$14.94M

Peer trimmed avg / median

Loading

Outlook Therapeutics Other Assets History

Loading

Outlook Therapeutics vs. peers: Other Assets Comparison

Loading

Outlook Therapeutics Other Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Outlook Therapeutics (OTLK) FAQ

Outlook Therapeutics (OTLK) currently reports a other assets of $15M as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Outlook Therapeutics's other assets history and peer comparisons.

Outlook Therapeutics's other assets changed from $0 to $15M (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Outlook Therapeutics reported $15M in other assets as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other assets of $15M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Outlook Therapeutics, and consider following OTLK for alerts when major investors trade the stock.

Outlook Therapeutics is classified in the Healthcare sector. On other assets, it currently shows $15M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OTLK with unrelated industries.